JUNO THERAPEUTICS INC's ticker is JUNO and the CUSIP is 48205A109. A total of 163 filers reported holding JUNO THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 1.30 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $437,000 | +76.2% | 9,750 | +17.5% | 0.00% | – |
| Q2 2017 | $248,000 | -53.6% | 8,300 | -70.7% | 0.00% | -100.0% |
| Q4 2016 | $534,000 | -80.9% | 28,349 | -69.6% | 0.00% | -80.0% |
| Q3 2016 | $2,796,000 | -63.3% | 93,166 | -53.0% | 0.01% | -28.6% |
| Q2 2016 | $7,624,000 | +273.2% | 198,334 | +269.7% | 0.01% | +75.0% |
| Q1 2016 | $2,043,000 | – | 53,650 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|